| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/29/2001 | EP1126867A2 A composition for the prevention and/or treatment of atherosclerosis |
| 08/29/2001 | EP1126865A2 Methods and compositions for treating or preventing peripheral neuropathies |
| 08/29/2001 | EP1126863A1 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2 |
| 08/29/2001 | EP1126856A1 Compounds and their therapeutic use with diabetic complications |
| 08/29/2001 | EP1126855A1 Methods for preventing/treating damage to sensory hair cells and cochlear neurons |
| 08/29/2001 | EP1126854A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues |
| 08/29/2001 | EP1126853A1 Controlled delivery of antidepressants |
| 08/29/2001 | EP1126852A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 08/29/2001 | EP1126851A1 Pharmaceutical formulations in hydroxypropylmethylcellulose capsules |
| 08/29/2001 | EP1126850A1 Treatment of disorders of the outer retina |
| 08/29/2001 | EP1126849A1 Heterocyclic potassium channel inhibitors |
| 08/29/2001 | EP1126848A1 Plastics container containing stabilised drug formulations |
| 08/29/2001 | EP1126847A1 Method for improving the pharmacokinetics of tipranavir |
| 08/29/2001 | EP1126846A1 Use of a nicotine receptor agonist in the treatment of obsessive compulsive disorder |
| 08/29/2001 | EP1126845A2 New use of immunosuppressants for mmp-mediated diseases |
| 08/29/2001 | EP1126844A1 Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation |
| 08/29/2001 | EP1126843A1 Compounds derived from an amine nucleus that are inhibitors of impdh enzyme |
| 08/29/2001 | EP1126842A2 Inhibition of the formation of vascular hyperpermeability |
| 08/29/2001 | EP1126841A1 Method of treating migraines and pharmaceutical compositions |
| 08/29/2001 | EP1126840A1 5ht(1) receptor agonists and metoclopramide for the treatment of migraine |
| 08/29/2001 | EP1126839A1 Substituted phenethylsulfones and method of reducing tnf alpha levels |
| 08/29/2001 | EP1126838A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 08/29/2001 | EP1126837A1 Fulvic acid and its use in the treatment of various conditions |
| 08/29/2001 | EP1126836A1 Benzamide potassium channel inhibitors |
| 08/29/2001 | EP1126835A1 Method for preventing increased iridial pigmentation during prostaglandin treatment |
| 08/29/2001 | EP1126834A1 Analgesic regimen |
| 08/29/2001 | EP1126832A2 Conductance of improperly folded proteins through the secretory pathway |
| 08/29/2001 | EP1126831A1 Method for treating insulin resistance through hepatic nitric oxide |
| 08/29/2001 | EP1126830A1 Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents |
| 08/29/2001 | EP1126829A1 Particles coated with granulated crystalline ibuprofen |
| 08/29/2001 | EP1126828A1 Oral administration of adenosine analogs |
| 08/29/2001 | EP1126827A2 Controlled delivery of active agents |
| 08/29/2001 | EP1126826A1 Multiparticulate modified release composition |
| 08/29/2001 | EP1126823A2 A process for the preparation of suspensions of drug particles for inhalation delivery |
| 08/29/2001 | EP1126822A1 Controlled release liquid delivery compositions with low initial drug burst |
| 08/29/2001 | EP1126821A1 Improved fast disintegrating tablet |
| 08/29/2001 | EP1126812A1 Treatment of skin with adenosine or adenosine analog |
| 08/29/2001 | EP1126792A1 Antimicrobial compositions that protect skin and dental tissue |
| 08/29/2001 | EP1126782A1 Method for improved imaging and photodynamic therapy |
| 08/29/2001 | EP1126762A1 Energetic rehydration fluid composition in particular for young animals no longer able to digest milk normally |
| 08/29/2001 | EP1054682B1 Use of hyperforin and hyperforin-containing extracts in the treatment and prophylaxis of dementing diseases |
| 08/29/2001 | EP1054665B1 Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the treatment of hyperglycemia |
| 08/29/2001 | EP1033985A4 Stable ascorbic acid preparation for topical use |
| 08/29/2001 | EP0968168B1 Aromatic tetracyclic compounds of the retinoid type, method for preparing and use |
| 08/29/2001 | EP0963198A4 ANTI-PARASITIC ACTION OF N,N-DIETHYL-m-TOLUAMIDE (DEET) AND FORMULATIONS THAT PROLONG ITS ACTIVITY IN THE SKIN |
| 08/29/2001 | EP0904299B1 Synthetic polysaccharides, method for preparing same and pharmaceutical compositions containing said polysaccharides |
| 08/29/2001 | EP0889877B1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS |
| 08/29/2001 | EP0876141B1 Preparations of non-steroidal analgesics |
| 08/29/2001 | EP0851866B1 Therapeutic compounds |
| 08/29/2001 | EP0831782A4 Methods and system for processing dispersible fine powders |
| 08/29/2001 | EP0828741B1 Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones |
| 08/29/2001 | EP0825983B1 Process for the preparation of 2,2'-bipyrrolyl-pyrromethene (prodigiosins) derivatives |
| 08/29/2001 | EP0809624B1 Alkylcarboxy amino acids-modulators of the kainate receptor |
| 08/29/2001 | EP0809622B1 Anti-inflammatory benzoic acid derivatives |
| 08/29/2001 | EP0789555B1 Dimeric acids in cosmetic or pharmaceutical compositions |
| 08/29/2001 | EP0775111B1 Stable vitamin a |
| 08/29/2001 | EP0768868B1 Pharmaceutical preparation with a hydrophobic active substance and an effervescent system, and process for preparing said preparation |
| 08/29/2001 | EP0736030B1 Tetrahydrofuran antifungals |
| 08/29/2001 | EP0711175B1 Topical compositions for re-epitheliazation of persistent epithelial defects |
| 08/29/2001 | EP0666747B1 Use of 17alpha-dihydroequilenin for lowering cholesterol |
| 08/29/2001 | EP0618925B1 Antisense oligonucleotides |
| 08/29/2001 | CN1310721A Medicine nitrate salts |
| 08/29/2001 | CN1310718A Heterocyclic compound as inhibitors of rotamase enzymes |
| 08/29/2001 | CN1310716A Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 08/29/2001 | CN1310715A Polymorph of ritonavir |
| 08/29/2001 | CN1310713A Substituted quinazoline derivatives |
| 08/29/2001 | CN1310709A N.N-substituted cyclic amine derivatives |
| 08/29/2001 | CN1310708A Substituted phenylamidines with antithrombotic action |
| 08/29/2001 | CN1310707A Novel 2,3,3A,4,9,9A hexahydro-8-hydroxy-1H-benz[f] indoles, a method for the production thereof, and their use as medicaments |
| 08/29/2001 | CN1310706A Inhibitors of phospholipase enzymes |
| 08/29/2001 | CN1310705A Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 08/29/2001 | CN1310702A Nitric ester and nitrate salts of specific drugs |
| 08/29/2001 | CN1310630A Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides |
| 08/29/2001 | CN1310629A Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions |
| 08/29/2001 | CN1310627A Hair growth/maintenance compositions and methods involving the same |
| 08/29/2001 | CN1310625A Use of alpha1 & beta1 integrin receptor inhibitors and TGF-beta1 inhibitors in the treatment of kidney disease |
| 08/29/2001 | CN1310624A Extraction method, pharmaceutical composition and a cosmetic composition |
| 08/29/2001 | CN1310623A Bioimplant formulation |
| 08/29/2001 | CN1310622A The use of valproic acid analog for the treatment and prevention of migraine and affective illness |
| 08/29/2001 | CN1310621A Substituted anilide compounds and methods |
| 08/29/2001 | CN1310620A Use of glucose uptake enhancer for reducing apoptosis |
| 08/29/2001 | CN1310619A Use of glucose uptake enhancer for reducing post-ischemic injury of the heart |
| 08/29/2001 | CN1310618A Inhibition of binding of Hox and homeodomain containing proteins and uses thereof |
| 08/29/2001 | CN1310617A Therapeutic system with addition of nacreous pigments |
| 08/29/2001 | CN1310616A Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 08/29/2001 | CN1310615A Estradiol-containing patch for transdermal administration of hormones |
| 08/29/2001 | CN1310614A Estradiol-containing patch for transdermal administration of hormones |
| 08/29/2001 | CN1310613A Rapidly disintegrable solid preparation |
| 08/29/2001 | CN1310612A Novel particulate formulations |
| 08/29/2001 | CN1310611A Pressurized metered dose inhalers and pharmaceutical aerosol formulations |
| 08/29/2001 | CN1310610A Pharmaceutical composition in particular for preventing and treating mucositis induced by radiotherapy or chemotherapy |
| 08/29/2001 | CN1310585A Process and production for promoting weight loss in overweight dogs |
| 08/29/2001 | CN1310195A Aqueous dispersion body of water insoluble organic ultraviolet ray filtering material |
| 08/29/2001 | CN1310180A New compound |
| 08/29/2001 | CN1310179A Oxamide being as IMPDH inhibitor |
| 08/29/2001 | CN1310178A Alkylation process and new hydroxy-phenyl-benzotriazole compound |
| 08/29/2001 | CN1310175A Process for producing bis (4-amino-1-pyridine) paraffins |
| 08/29/2001 | CN1310169A Anils with nitric oxide synzyme inhibiting function |
| 08/29/2001 | CN1310025A Therapeutical compound and its application |
| 08/29/2001 | CN1310017A Chinese patent medicine for stopping pain and abstaining from drugs |